On August 16, 2024, the European Centre for Disease Prevention and Control (ECDC) published a Rapid Risk Assessment for the EU/EEA regarding the Mpox epidemic caused by monkeypox virus clade I, with no change in risk levels or recommendations. An epidemiological update on August 26, 2024, reported a total of 102,977 confirmed Mpox cases globally since monitoring began in 2022, with 219 deaths. The majority of cases are from Africa, particularly the Democratic Republic of Congo. The Africa CDC declared mpox a Public Health Emergency of Continental Security on August 13, 2024, and the WHO followed by declaring it a Public Health Emergency of International Concern on August 14, 2024. The ECDC has issued additional recommendations for Substances of Human Origin (SoHO) professionals, advising careful screening of donors from affected regions and deferral guidelines for those exposed to Mpox.
Read more here